×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

Kala-azar: There is now better, shorter treatment

Kala-azar is caused by protozoan parasites transmitted by the bite of infected female phlebotomine sandflies. [iStockphoto]

The Drugs for Neglected Diseases Initiative (DNDi) has said Kenyans suffering from Visceral Leishmaniasis (Kala-azar) will no longer go through the painful 17-day injection treatment after the successful clinical trial of a better, shorter new combination of treatment.

Trials that were conducted in Eastern Africa showed that combining Miltefosine (oral drug) and Paromomycin (injection drug) reduced daily injections and hospitalisation from 17 to 14 days.

Get Full Access for Ksh299/Week
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Athletics
Ebenyo among stars to battle for glory in Mumias
Athletics
Kipchoge urges corporates to continue supporting sports
Hockey
USIU-A target podium finish at ACCC
Sports
DT finest Njoroge turns focus to prestigious Sunshine Tour